BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 26363896)

  • 21. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
    Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
    Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cooperative Ewing's Sarcoma Studies 81/86: pathologico-anatomic and immunohistochemical findings and differential diagnosis of Ewing sarcoma].
    Schmidt D; Harms D
    Klin Padiatr; 1988; 200(3):236-42. PubMed ID: 3062261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ewing's sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) differentiation in endometrial serous carcinomas.
    Quddus MR; Rashid L; Sung CJ; Steinhoff MM; Cunxian Zhang ; Lawrence WD
    Reprod Sci; 2009 Jun; 16(6):591-5. PubMed ID: 19318687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primitive neuroectodermal tumor and Ewing's sarcoma.
    Dehner LP
    Am J Surg Pathol; 1993 Jan; 17(1):1-13. PubMed ID: 8383465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors.
    Grier HE
    Pediatr Clin North Am; 1997 Aug; 44(4):991-1004. PubMed ID: 9286296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced or absent expression and codon 201Gly/Arg polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family.
    Choi SH; Kong XT; Taki T; Tsuchida Y; Kawaguchi H; Kato H; Hanada R; Look AT; Hayashi Y
    Int J Mol Med; 2000 Oct; 6(4):463-7. PubMed ID: 10998440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycogen-containing neuroblastoma with clinical and histopathologic features of Ewing's sarcoma.
    Triche TJ; Ross WE
    Cancer; 1978 Apr; 41(4):1425-32. PubMed ID: 639002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
    Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
    J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors.
    Hartman KR; Triche TJ; Kinsella TJ; Miser JS
    Cancer; 1991 Jan; 67(1):163-71. PubMed ID: 1985713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 and ras mutations in Ewing's sarcoma.
    Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
    Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma.
    Lollini PL; Palmieri G; De Giovanni C; Landuzzi L; Nicoletti G; Rossi I; Griffoni C; Frabetti F; Scotlandi K; Benini S; Baldini N; Santoni A; Nanni P
    Int J Cancer; 1997 May; 71(5):732-6. PubMed ID: 9180138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The differential effects of the radioprotectant drugs amifostine and sodium selenite treatment in combination with radiation therapy on constituent bone cells, Ewing's sarcoma of bone tumor cells, and rhabdomyosarcoma tumor cells in vitro.
    Margulies BS; Damron TA; Allen MJ
    J Orthop Res; 2008 Nov; 26(11):1512-9. PubMed ID: 18473385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
    Fellinger EJ; Garin-Chesa P; Glasser DB; Huvos AG; Rettig WJ
    Am J Surg Pathol; 1992 Aug; 16(8):746-55. PubMed ID: 1497115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ewing's sarcoma/PNET of kidney in 13-year-old girl.
    Badar Q; Ali N; Abbasi N; Ashraf S; Karsan F; Hashmi R
    J Pak Med Assoc; 2010 Apr; 60(4):314-5. PubMed ID: 20419980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Ewing's sarcoma family of tumors: Ewing's sarcoma and peripheral primitive neuroectodermal tumor of bone and soft tissue.
    Granowetter L; West DC
    Cancer Treat Res; 1997; 92():253-308. PubMed ID: 9494764
    [No Abstract]   [Full Text] [Related]  

  • 36. Current Status of Proteomics in Ewing's Sarcoma.
    Kondo T
    Proteomics Clin Appl; 2019 May; 13(3):e1700130. PubMed ID: 29992772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) of the penis.
    Kilicaslan I; Karayigit E; Bulut F; Basaran M; Dizdar Y; Aslay I; Uysal V
    Int Urol Nephrol; 2008; 40(1):113-5. PubMed ID: 17952624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
    Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
    Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primitive neuroectodermal tumor/extraosseus Ewing sarcoma of the temporal bone].
    Souvirón Encabo R; Arenas Britez O; Gil R; Pérez-Luengo E; Scola Yurrita B
    Acta Otorrinolaringol Esp; 2005 Jan; 56(1):38-40. PubMed ID: 15747723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary intracranial peripheral PNET"--a case report and review.
    Velivela K; Rajesh A; Uppin MS; Purohit AK
    Neurol India; 2014; 62(6):669-73. PubMed ID: 25591683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.